Literature DB >> 3033969

Hormonal and metabolic responses to cardiac surgery with sufentanil-oxygen anaesthesia.

S Lacoumenta, T H Yeo, J L Paterson, J M Burrin, G M Hall.   

Abstract

The effects of sufentanil, 10 and 20 micrograms kg-1 on the hormonal and metabolic responses to coronary artery surgery were compared in 20 patients. The most important finding was that the changes in circulating beta-endorphin, ACTH, cortisol, GH, glucose, lactate and glycerol concentrations during and after cardiac surgery were similar with both doses of sufentanil. Although sufentanil prevented a significant increase in plasma beta-endorphin, ACTH and cortisol values until 6 h after cardiopulmonary bypass (CPB), a significant increase in GH secretion occurred with the onset of CPB. Plasma insulin concentrations declined significantly after 30 min CPB, but recovered after 60 min CPB with the restoration of normothermia. Blood glucose values did not change during surgery before CPB, but started to rise with the onset of CPB and continued to increase significantly in the postoperative period. Changes in blood lactate and plasma glycerol concentrations primarily reflected the load of CPB and the effects of heparin, respectively. The results show that increasing the dose of sufentanil up to 20 micrograms kg-1 does not result in better suppression of the endocrine and metabolic changes associated with cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033969     DOI: 10.1111/j.1399-6576.1987.tb02562.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  2 in total

Review 1.  Sufentanil. A review of its pharmacological properties and therapeutic use.

Authors:  J P Monk; R Beresford; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

2.  Genetic variation of TLR4 influences immunoendocrine stress response: an observational study in cardiac surgical patients.

Authors:  Alexander Koch; Lutz Hamann; Matthias Schott; Olaf Boehm; Dirk Grotemeyer; Muhammed Kurt; Carsten Schwenke; Ralf R Schumann; Stefan R Bornstein; Kai Zacharowski
Journal:  Crit Care       Date:  2011-04-05       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.